S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction

Neuroscience Research

Volumn 56, Issue 1, 2006, Pages 39-44

  Herrera Mundo, María N ^a   Silva Adaya, Daniela ^a   Maldonado, Perla D ^a   Galván Arzate, Sonia ^a   Andrés Martínez, Leticia ^a   Pérez De La Cruz, Verónica ^a   Pedraza Chaverrí, José ^b   Santamaría, Abel ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

Author keywords

3 Nitropropionic acid; Antioxidant defense; Garlic derived compounds; Hyperactivity; Mitochondrial reducing activity; S Allylcysteine; Superoxide dismutase

Indexed keywords

3 (3,5 DIMETHYLTHIAZOL 2 YL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 NITROPROPIONIC ACID; BIOLOGICAL MARKER; BROMINE DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE; MANGANESE SUPEROXIDE DISMUTASE; S ALLYLCYSTEINE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR DISORDER; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERACTIVITY; LIPID PEROXIDATION; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

AKATHISIA, DRUG-INDUCED; ANIMALS; ANTINEOPLASTIC AGENTS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CONVULSANTS; CORPUS STRIATUM; CYSTEINE; ISOENZYMES; LIPID PEROXIDATION; MALE; MITOCHONDRIA; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONIC ACIDS; PSYCHOMOTOR AGITATION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 33747882445     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.04.018     Document Type: Article

References (39)

1. Alexi T., Hughes P.E., Faull R.L., and Williams C.E. 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 9 (1998) R57-R64
2. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storey E., Srivastava R., Rosen B.R., and Hyman B.T. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13 (1993) 4181-4192
3. Berridge M.V., and Tan A.S. Characterization of cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303 (1993) 474-482
4. Binienda Z., and Kim C.S. Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration. Neurosci. Lett. 230 (1997) 199-201
5. Binienda Z., Simmons C., Hussain S., Slikker Jr. W., and Ali S.F. Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain. Neurosci. Lett. 251 (1998) 173-176
6. Bizat N., Hermel J.M., Boyer F., Jacquard C., Créminon C., Ouary S., Escartin C., Hantraye P., Kajewski S., and Brouillet E. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. J. Neurosci. 23 (2003) 5020-5030
7. Borlongan C.V., Koutouzis T.K., Freeman T.B., Hauser R.A., Cahill D.W., and Sanberg P.R. Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model. Brain Res. Brain Res. Protoc. 1 (1997) 253-257
8. Borlongan C.V., Koutouzis T.K., and Sanberg P.R. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci. Biobehav. Rev. 21 (1997) 289-293
9. Borlongan C.V., Nishino H., and Sanberg P.R. Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation. Neurosci. Res. 28 (1997) 185-189
10. Fontaine M.A., Geddes J.W., Banks A., and Butterfield D.A. Effect of exogenous and endogenous antioxidants on 3-nitropropionic acid-induced oxidative stress and striatal lesions: insights into Huntington's disease. J. Neurochem. 75 (2000) 1709-1715
11. Fu Y., He F., Zhang S., Huang J., Zhang J., and Jiao X. 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum. Neurotoxicol. Teratol. 17 (1995) 333-339
12. Fu Y.T., He F.S., Zhang S.L., and Zhang J.S. Lipid peroxidation in rats intoxicated with 3-nitropropionic acid. Toxicon 33 (1995) 327-331
13. Greene J.G., Sheu S.S., Gross R.A., and Greenamyre J.T. 3-Nitropropionic acid exacerbates N-methyl-d-aspartate toxicity in striatal culture by multiple mechanisms. Neuroscience 84 (1998) 503-510
14. Iqbal J., and Whitney P. Use of cyanide and diethyldithiocarbamate in the assay of superoxide dismutases. Free Radic. Biol. Med. 10 (1991) 69-77
15. Ito Y., Ito M., Takagi N., Saito H., and Ishige K. Neurotoxicity induced by amyloid beta-peptide and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-l-cysteine, a garlic compound. Brain Res. 985 (2003) 98-107
16. Kim K.M., Chun S.B., Koo M.S., Choi W.J., Kim T.W., Kwon Y.G., Chung H.T., Billiar T.R., and Kim Y.M. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic. Biol. Med. 30 (2001) 747-756
17. Kim J.H., Kim S., Yoon I.S., Lee J.H., Jang B.J., Jeong S.M., Lee J.H., Lee B.H., Han J.S., Oh S., Kim H.C., Park T.K., Rhim H., and Nah S.Y. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats. Neuropharmacology 48 (2005) 743-756
18. Lian X.Y., Zhang Z., and Stringer J.L. Protective effects of ginseng components in a rodent model of neurodegeneration. Ann. Neurol. 57 (2005) 642-648
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Ludolph A.C., He F., Spencer P.S., Hammerstad J., and Sabri M. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18 (1991) 492-498
21. Massieu L., Morán J., and Christen Y. Effect of Ginkgo biloba (EGb 761) on staurosporine-induced neuronal death and caspase activity in cortical cultured neurons. Brain Res. 1002 (2004) 76-85
22. Moriguchi T., Matsuura H., Kodera Y., Itakura Y., Katsuki H., Saito H., and Nishiyama N. Neurothropic activity of organosulfur compounds having a thioallyl group on cultured rat hippocampal neurons. Neurochem. Res. 22 (1997) 1449-1452
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
24. Nam E., Lee S.M., Koh S.E., Joo W.S., Maeng S., Im H.I., and Kim Y.S. Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum. Brain Res. 1046 (2005) 90-96
25. Nishiyama N., Moriguchi T., Morihara N., and Saito H. Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice. J. Nutr. 131 (2001) 1093S-1095S
26. Numagami Y., and Ohnishi S.T. S-Allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J. Nutr. 131 (2001) 1100S-1105S
27. Pang Z., and Geddes J.W. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17 (1997) 3064-3073
28. Pérez-De La Cruz V., González-Cortés C., Pedraza-Chaverrí J., Maldonado P.D., Andrés-Martínez L., and Santamaría A. Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes. Brain Res. Bull. 68 (2006) 379-383
29. Pérez-Severiano F., Salvatierra-Sánchez R., Rodríguez-Pérez M., Cuevas-Martínez E.Y., Guevara J., Limón D., Maldonado P.D., Medina-Campos O.N., Pedraza-Chaverrí J., and Santamaría A. S-Allylcysteine prevents amyloid-β peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. Eur. J. Pharmacol. 489 (2004) 197-202
30. Pérez-Severiano F., Rodríguez-Pérez M., Pedraza-Chaverrí J., Maldonado P.D., Medina-Campos O.N., Ortíz-Plata A., Sánchez-García A., Villeda-Hernández J., Galván-Arzate S., Aguilera P., and Santamaría A. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem. Int. 45 (2004) 1175-1183
31. Rodríguez-Martínez E., Rugerio-Vargas C., Rodríguez A.I., Borgonio-Pérez G., and Rivas-Arancibia S. Antioxidant effects of taurine, Vitamin C, and Vitamin E on oxidative damage in hippocampus caused by the administration of 3-nitropropionic acid in rats. Int. J. Neurosci. 114 (2004) 1133-1145
32. Santamaría A., Salvatierra-Sánchez R., Vázquez-Román B., Santiago-López D., Villeda-Hernández J., Galván-Arzate S., Jiménez-Capdeville M.E., and Ali S.F. Protective effects of selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J. Neurochem. 86 (2003) 479-488
33. Shih A.Y., Imbeault S., Barakauskas V., Erb H., Jiang L., Li P., and Murphy T.H. Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 280 (2005) 22925-22936
34. Schulz J.B., Henshaw D.R., MacGarvey U., and Beal M.F. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem. Int. 29 (1996) 167-171
35. Tavares R.G., Santos C.E., Tasca C.I., Wajner M., Souza D.O., and Dutra-Filho C.S. Inhibition of glutamate uptake into synaptic vesicles from rat brain by 3-nitropropionic in vitro. Exp. Neurol. 172 (2001) 250-254
36. Túnez I., Montilla P., Del Carmen-Muñoz M., Feijóo M., and Salcedo M. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. J. Pineal Res. 37 (2004) 252-256
37. Wüllner U., Young A.B., Penney J.B., and Beal M.F. 3-Nitropropionic acid toxicity in the striatum. J. Neurochem. 63 (1994) 1772-1781
38. Yang L., Calingasan N.Y., Chen J., Ley J.J., Becker D.A., and Beal M.F. A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities. Exp. Neurol. 191 (2005) 86-93
39. Zeevalk G.D., Derr-Yellin E., and Nicklas W.J. NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64 (1995) 455-458